Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
69.60
+0.40 (0.58%)
Nov 16, 2026, 5:35 PM CET

BME:ROVI Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
205.57140.44136.88170.34199.67153.08
Depreciation & Amortization
34.4228.7626.9223.4421.8420.3
Other Amortization
1.621.621.090.91.031.06
Loss (Gain) From Sale of Assets
1.780.014.39---
Loss (Gain) From Sale of Investments
-0.010.51-0.080.22-1.83-1.16
Loss (Gain) on Equity Investments
-0.2-0.060.140.13-0.2-0.18
Stock-Based Compensation
-----1.4
Provision & Write-off of Bad Debts
-0.31-0.31-7.97-0.040.04-0.27
Other Operating Activities
-64.7711.55-32.06-47.2874.0339.24
Change in Accounts Receivable
-55.84-30.1913.4119.47-26.82-74.19
Change in Inventory
66.442.9911.87-29.29-71.59-23.43
Change in Accounts Payable
8.99-7.75-16.36-23.9241.6735.36
Change in Other Net Operating Assets
-0.94-0.50.04-0.7-0.23-1.78
Operating Cash Flow
196.72187.08138.28113.25237.6149.44
Operating Cash Flow Growth
12.72%35.29%22.10%-52.34%58.99%218.80%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-75.94-65.21-59.12-53.79-50.72-40.22
Sale of Property, Plant & Equipment
0.060.140.040.380.080.03
Sale (Purchase) of Intangibles
-3.74-2.6-3.1-1.39-0.67-0.72
Investment in Securities
-3.46-3.46-19.011.29-5.85-
Other Investing Activities
-19.222.660.131.490.010.07
Investing Cash Flow
-102.31-68.48-81.06-52.03-57.15-40.84

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-47.6196.950.731.41.34
Long-Term Debt Repaid
--46.79-51.71-13.65-6.77-6.19
Net Debt Issued (Repaid)
-28.610.8245.24-12.92-5.37-4.85
Issuance of Common Stock
65.0954.8541.9252.6477.7742.33
Repurchase of Common Stock
-65.54-54.86-89.71-133.9-177.01-78.79
Common Dividends Paid
-49.07-47.83-56.45-69.05-51.01-21.13
Other Financing Activities
5.34-0.793.642.391.08-0.29
Financing Cash Flow
-72.78-47.81-55.36-160.84-154.54-62.73

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
21.6770.791.86-99.6225.9145.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
120.78121.8779.1659.45186.88109.22
Free Cash Flow Growth
8.79%53.95%33.15%-68.19%71.10%1348.77%
Free Cash Flow Margin
14.58%16.39%10.37%7.17%22.86%16.84%
Free Cash Flow Per Share
2.362.381.551.123.501.97
Levered Free Cash Flow
97.1582.344.8525.36135.9266.2
Unlevered Free Cash Flow
99.5683.946.0925.95136.4566.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.352.31.770.390.290.29
Cash Income Tax Paid
47.0441.9344.2340.8643.8923.86
Change in Working Capital
18.614.558.96-34.45-56.97-64.03